Can amylin drugs take over from GLP-1s in obe­si­ty? Part­ner­less Zealand thinks so

In­vestors who were ea­ger for news of a part­ner­ing deal for the Zealand Phar­ma’s mid-stage as­set pe­tre­lin­tide had a dis­ap­point­ing Thurs­day morn­ing: The com­pa­ny re­port­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER